Agenus (AGEN) Depreciation & Amortization (CF) (2010 - 2026)
Agenus (AGEN) posted quarterly Depreciation & Amortization (CF) of $583000.0 for Q1 2026, down 81.8% year-over-year from $3.2 million in Q1 2025, and down 2.35% quarter-over-quarter from $597000.0 in Q4 2025.
Analysis
Agenus (AGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Agenus' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $583000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 81.8% year-over-year to $583000.0; the TTM figure through Mar 2026 stood at $7.4 million (down 43.98% YoY), while the FY2025 annual figure was $10.0 million, down 25.06% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $583000.0, down from $597000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $5.2 million in Q4 2023, with the low at $583000.0 in Q1 2026.
- The 5-year median for Depreciation & Amortization (CF) is $3.0 million (2023), against an average of $2.6 million.
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) jumped 175.33% in 2023, then sank 81.8% in 2026.
- Agenus' Depreciation & Amortization (CF) stood at $1.9 million in 2022, then surged by 175.33% to $5.2 million in 2023, then tumbled by 37.32% to $3.3 million in 2024, then sank by 81.69% to $597000.0 in 2025, then slipped by 2.35% to $583000.0 in 2026.
- Business Quant data shows AGEN's Depreciation & Amortization (CF) at $583000.0 in Q1 2026, $597000.0 in Q4 2025, and $3.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Agenus | 343.02 Mn | 343.02 Mn | 34.52 Mn | 517,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 517,000.00 |
| Mar 31, 2026 | 583,000.00 |
| Dec 31, 2025 | 597,000.00 |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Dec 31, 2023 | 5.20 Mn |
| Sep 30, 2023 | 2.85 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 2.56 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.66 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.68 Mn |